Fresenius SE & Co KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius SE & Co KGaA with three other
health care providers in Europe:
sales of 2.39 billion Euro [US$2.53 billion]
Ramsay Generale De Sante
(1.79 billion Euro [US$1.89 billion]
of which 44%
was Medicine, Surgery and Obstetrics), and
Fresenius Medical Care AG & Co. KGaA
(15.18 billion Euro [US$16.06 billion]
of which 71%
was North America).
During the year ended December of 2015, sales at
Fresenius SE & Co KGaA were 28.00 billion Euro (US$29.62 billion).
increase of 19.3%
versus 2014, when the company's sales were 23.46 billion Euro.
This was the fifth consecutive year of sales increases at Fresenius SE & Co KGaA
(and since 2010, sales have increased a total of 75%).
Sales of Ifrs-Reconciliation saw an increase
that was more than double the company's growth rate: sales were up
61.8% in 2015, from
228.00 million Euro to 369.00 million Euro.
Fresenius SE & Co KGaA also saw significant increases in sales in
Fresenius Medical Care (up 26.9% to 15.06 billion Euro)